Category - Investments and funding

Goodbye 2022 – Hello 2023

We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more

Time Is What We Want Most – Why Wasting Any More of It?

As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more

Deepcell Aims to Create a Single Cell Morpholome Platform

This month’s “Company Spotlight” takes a closer look at Deepcell, a company that is building a platform for the identification, isolation, and classification of viable cells based on their morphological distinctions for...read more

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets Genomenon®Inc., an AI-driven genomics company, today announced the completion of a...read more

Category - Investments and funding

Goodbye 2022 – Hello 2023

Time Is What We Want Most – Why Wasting Any More of It?

Deepcell Aims to Create a Single Cell Morpholome Platform

We Invite you to join enlightenbio’s Subject Matter Expert Network!

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure

Armonica Technologies Closes B Round Financing

Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing

Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

Genoox accelerates genomic data community platform expansion with $8M round and appointment of new Board Chair

Geisinger awarded $3.6 million to study genetics of cancer

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth

Genomenon Completes $5.3M Financing Round

Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders

Genomics plc completes oversubscribed $30M funding round

WuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector